1 |
Soriano JB, Lamprecht B. Chronic obstructive pulmonary disease: a worldwide problem[J]. Med Clin North Am, 2012, 96(4): 671-680.
|
2 |
任成山,王关嵩,钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
3 |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China ( the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
|
4 |
Gómez FP, Rodriguez-Roisin R. Global Initiative for Chronic Obstructive Lung Disease(GOLD) guidelines for chronic obstructive pulmonary disease[J]. Curr Opin Pulm Med, 2011, 8(2): 81-86.
|
5 |
de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease(COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population[J]. PLoS One, 2013, 8(5): e62985.
|
6 |
Chung JW, Kong KA, Lee JH, et al. Characteristics and self-rated health of overlap syndrome[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9:795-804.
|
7 |
Zareifopoulos N, Bellou A, Spiropoulou A, et al. Prevalence, contribution to disease burden and management of comorbid depression and anxiety in chronic obstructive pulmonary disease:a narrative review[J]. COPD, 2019, 16(5-6): 406-417.
|
8 |
Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002[J]. JAMA, 2005, 294: 1255-1259.
|
9 |
Sciriha A, Lungaro-Mifsud S, Scerri J, et al. Health status of COPD patients undergoing pulmonary rehabilitation: A comparative responsiveness of the CAT and SGRQ[J]. Chron Respir Dis, 2017, 14(4): 352-359.
|
10 |
Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population based survey[J]. Am J Respir Crit Care Med, 2007, 176: 753-760.
|
11 |
唐鲜娥,潘江其,周发伟,等. Hcy、IL-1β与冠心病患者伴发抑郁的相关性研究[J]. 同济大学学报(医学版), 2017, 38(1): 90-93.
|
12 |
Yao HM, Xiao RS, Cao PL, et al. Risk factors for depression in patients with chronic obstructive pulmonary disease[J]. World J Psychiatr, 2020, 10(4): 59-70.
|
13 |
Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: recognition and management[J]. Cleve Clin J Med, 2018, 85(2 Suppl 1): S11-S18.
|
14 |
Bock K, Bendstrup E, Hilberg O, et al. Screening tools for evaluation of depression in chronic obstructive pulmonary disease (COPD). A systematic review[J]. Eur Clin Respir J, 2017, 4(1): 1332931.
|
15 |
Hynninen KM, Breitve MH, Wiborg AB, et al. Psychological characteristics of patients with chronicobstructive pulmonary disease:a review[J]. J Psychosom Res, 2005, 59: 429-443.
|
16 |
陈华萍,尹 燕,贺斌峰,等. 慢性阻塞性肺疾病合并焦虑抑郁的临床分析[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(6): 677-681.
|
17 |
Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease:effect on mortality, hospital readmission, symptom burden, functional status, and quality of life[J]. Arch Intern Med, 2007, 167(1): 60-67.
|
18 |
Montserrat-Capdevila J, Godoy P, Marsal JR, et al. Mental disorders in chronic obstructive pulmonary diseases[J]. Perspect Psychiatr Care, 2018, 54(3): 398-404.
|
19 |
董明林,熊梦清,胡卫华,等. 慢性阻塞性肺疾病合并焦虑抑郁症的临床特征及相关危险因素分析[J]. 国际呼吸杂志,2021, 41(4): 253-258.
|
20 |
Mehta JR, Ratnani IJ, Dave JI, et al. Association of psychiatric co-morbidities and quality of life with severity of chronic obstructive pulmonary disease[J]. East Asian Arch Psychiatry, 2014, 24(4): 148-155.
|
21 |
Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test[J]. Eur Respir J, 2009, 34: 648-654.
|
22 |
Lee YS, Park S, Oh YM, et al. Korean COPD Study Group. Chronic obstructive pulmonary disease assessment test can predict depression: a prospective multi-center study[J]. J Korean Med Sci, 2013, 28: 1048-1054.
|
23 |
Guillien A, Laurent L, Soumagne T, et al. Anxiety and depression among dairy farmers: the impact of COPD[J]. Int J Chron Obstruct Pulmon Dis, 2018, 13: 1-9.
|
24 |
von Siemens SM, Jörres RA, Behr J, et al. COSYCONET study group. Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study[J]. Respir Res, 2019, 20: 30.
|
25 |
Löwe B, Schenkel I, Carney-Doebbeling C, et al. Responsiveness of the PHQ-9 to psychopharmacological depression treatment[J]. Psychosomatics, 2006, 47: 62-67.
|
26 |
Matte DL, Pizzichini MM, Hoepers AT, et al. Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies[J]. Respir Med, 2016, 117: 154-161.
|
27 |
郭 晶,牛津牧,陈 哲. COPD患者抑郁的发病情况[J]. 山东医药,2015, 55(39): 69 -71, 72.
|
28 |
江 宁,尹 燕,侯 刚,等. 哮喘-慢阻肺重叠患者焦虑、抑郁状态调查分析[J]. 中国医师杂志,2021(7): 1007-1011.
|
29 |
Bordoni B, Marelli F, Morabito B, et al. Share Depression, anxiety and chronic pain in patients with chronic obstructive pulmonary disease: the influence of breath[J]. Monaldi Arch Chest Dis, 2017, 87(1): 811.
|
30 |
Zhovanyk NV, Tovt-Korshynska MI. Interaction between clinical and psychological changes among patients with chronic obstructive pulmonary disease and pulmonary tuberculosis co-morbidity[J]. Wiad Lek, 2019, 72(4): 635-638.
|
31 |
Panagioti M, Scott C, Blakemore A, et al. Overview of the prevalence,impact, and management of depression and anxiety in chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9: 1289-1306.
|